Identifying and managing heavy menstrual bleeding in primary care

This Research Review E-Learning Module is intended for GPs. It covers the identification, assessment and management of heavy menstrual bleeding (HMB), and is based on a Research Review Educational Series publication entitled “Identifying and managing heavy menstrual bleeding in primary care”.

Before starting the module please read the Research Review Educational Series, accessed through the link below:

CLICK HERE
to access the quiz source material
Educational Series - Identifying and managing heavy menstrual bleeding in primary care

The PDF through the link above can be viewed on screen, saved and printed. 

This E-Learning Module covers:

• Causes and sequelae of HMB
• Identification and assessment of HMB
• Use of the levonorgestrel-releasing intrauterine device (LNG-IUD) for HMB
• Oral treatments for HMB
• Surgical options for HMB

Learning outcomes

After completing this module, you should have an improved understanding of how to:

• Undertake a systematic clinical assessment of patients with HMB
• Identify patients requiring a pelvic ultrasound and/or endometrial biopsy
• Identify treatment options for HMB available in the primary care setting
• Identify patients with HMB needing referral for specialist care

Contributing experts

Expert commentary is provided by:

Dr Gemma Nightingale, a Consultant Obstetrician and Gynaecologist working at Hutt, Boulcott and Bowen Hospitals. Gemma has a special interest in urogynaecology and laparoscopic surgery.

Module questions have been developed by Dr Chris Tofield, who works in primary care skin cancer treatment and as a consultant to Research Review.

Accreditation

Research Review publications, videos and e-Learning modules have been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and have been approved for up to 2 CME credits per learning hour for Continuing Professional Development (CPD) purposes. Please CLICK HERE to download RNZCGP Dashboard.

Sponsorship

This module has been created with an unrestricted grant from Bayer. The content is entirely independent and is based on the published studies and the author’s opinion.